Alyeska Investment Group, L.P. Tango Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.01 - $10.94 $350,500 - $547,000	-50,000 Reduced 40.21%	74,338 $563,000
Q4 2021 Feb 14, 2022	SELL	$9.55 - $14.29 $2.87 Million - $4.29 Million	-300,300 Reduced 70.72%	124,338 $1.36 Million
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $4.06 Million - $7.35 Million	424,638 New	424,638 $5.49 Million

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $359M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.